ABBV vs META: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Meta Platforms, Inc. · Communication Services
$611.40
+12.9% upside to fair value
High Conviction
Grade A-
QuantHub Verdict
META has more upside to fair value
(+12.9%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
META |
| Current Price |
$208.05 |
$611.40 |
| Fair Value Estimate |
$217.50 |
$690.00 |
| Upside to Fair Value |
+4.5%
|
+12.9%
|
| Market Cap |
$367.9B |
$1,541.3B |
| Forward P/E |
14.9x
|
23.0x
|
| EV / EBITDA |
16.7x
|
18.0x
|
| Price / Sales |
6.1x
|
7.7x
|
| Price / FCF |
20.9x
|
33.4x
|
| Revenue Growth YoY |
+8.6%
|
+22.2%
|
| Gross Margin |
83.7%
|
82.0%
|
| Operating Margin |
34.7%
|
41.4%
|
| Return on Equity |
-129.24%
|
30.6%
|
| Dividend Yield |
3.2% |
0.4% |
| FCF Yield |
4.78%
|
3.0%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Meta Platforms operates the world's largest social media ecosystem (Facebook, Instagram, WhatsApp, Threads) reaching 3.3B+ daily users, generating $201B in revenue predominantly from digital advertising. The company's 82% gross margins and AI-powered ad targeting create an extraordinarily profitable core business. Trading at its 5-year P/E low of 25.5x despite 22% revenue growth, META is cheap on…
Accumulation Zones
| Metric |
ABBV |
META |
| Zone Low |
$163.13 |
$520.00 |
| Zone High |
$184.88 |
$590.00 |
| In Buy Zone? |
No
|
No
|